Related Experiment Video
Updated: Aug 28, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Tuberculosis-Associated Anemia: A Narrative Review
Thejaswi Dasaradhan1, Jancy Koneti2, Revanth Kalluru2
1Research, Narayana Medical College, Nellore, IND.
Tuberculosis (TB) is an airborne illness often linked with anemia. This review explores how TB causes anemia, identifies risk factors, and evaluates treatments like iron therapy for TB-associated anemia.
Area of Science:
- Infectious Diseases
- Hematology
- Immunology
Background:
- Tuberculosis (TB) is an airborne infectious disease primarily affecting the lungs.
- Anemia is a frequent comorbidity in TB patients, complicating disease management.
- Systemic inflammation and cytokine dysregulation are hallmarks of TB.
Purpose of the Study:
- To elucidate the pathogenesis of anemia in TB patients.
- To identify risk factors associated with developing anemia in TB.
- To review and assess the efficacy of therapeutic interventions for TB-associated anemia.
Main Methods:
- Comprehensive literature review of studies on TB and anemia.
- Analysis of the role of cytokines in anemia development during TB.
- Evaluation of therapeutic strategies including antitubercular and iron therapy.
Main Results:
- Cytokines play a significant role in the pathogenesis of anemia in TB.
- Specific risk factors increase the likelihood of anemia in TB patients.
- Antitubercular therapy and iron supplementation show varying efficacy in managing anemia.
Conclusions:
- Understanding TB-induced anemia requires examining pathogenesis and cytokine involvement.
- Identifying risk factors aids in proactive anemia management for TB patients.
- Hepcidin and ferritin measurements are crucial for assessing and managing anemia in TB.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...